WilliamDavidKoltunMD

Obstetrics & Gynecology • San Diego, CA

General Gynecology

Director of Medical Center for Clinical Research

Join to view full profile

Dr. Koltun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koltun's full profile

Already have an account?

Office
9040 Friars Rd
Suite 540
San Diego, CA 92108
Phone+1 619-787-7009

Fax+1 619-521-2830

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 1975 - 1979
Keck School of Medicine of the University of Southern CaliforniaClass of 1975

Certifications & Licensure

CA State Medical License 1977 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Clinical Trials

The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
Completed
Phase 2
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
Completed
Phase 2
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Start of enrollment: 2014 Jun 01
Completed
Phase 3
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine Start of enrollment: 2018 Mar 14
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

25 citations
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Control...
Nicholas Van Wagoner, Kenneth H. Fife, Peter A. Leone, David I. Bernstein, Terri Warren
The Journal of Infectious Diseases. 2018-11-05
21 citations
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinar...
Fernand Labrie, David F Archer, William Koltun, Andrée Vachon, Douglas Young
Menopause. 2018-11-01
33 citations
A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vag...
Jane R. Schwebke, Franklin G. Morgan, William D. Koltun, Paul Nyirjesy
American Journal of Obstetrics and Gynecology. 2017-09-01

Journal Articles

Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial
David I Bernstein, John Kriesel, William Koltun, Gregg Lucksinger, Peter A Leone, Richard Beigi, Stephen Tyring, Richard M Novak, Seth Hetherington, The Journal of Infectious Diseases